Magnesium sulfate therapy in patients with acute neuronal damage: The problem of intravenous administration.
Dohi
Kenji
K
Ohtaki
Hirokazu
H
Shioda
Seiji
S
Aruga
Tohru
T
D001682:Biological Availability; D001921:Brain / Q000378:metabolism*; D001930:Brain Injuries / Q000188:drug therapy*; D006801:Humans; D007262:Infusions, Intravenous; D008274:Magnesium / Q000134:cerebrospinal fluid*; D008278:Magnesium Sulfate / Q000008:administration & dosage / Q000493:pharmacokinetics*; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000494:pharmacology*
D018696:Neuroprotective Agents; D008278:Magnesium Sulfate; D008274:Magnesium